Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1617-2020Class II

TEG Manager software versions used in conjunction with TEG 5000 are 1.1.0, 3.0.0, 4.0.0, 4.1.0 and 4.1.1...

Haemonetics Corporation / initiated 2020-02-19 / Terminated / root cause: software

Haemonetics Corporation began a recall of TEG Manager software versions used in conjunction with TEG 5000 are 1.1.0, 3.0.0, 4.0.0, 4.1.0 and 4.1.1. Intended: For in vitro coagulation studies on . FDA classified it as Class II and gives the reason as "Software defect in TEG Manager impacts the displayed alert for out of range test results. Due to this defect, reference range values received from TEG 5000 and displayed on the TEG Manager test result screen are rounded...". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-1617-2020
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Haemonetics Corporation
Product
TEG Manager software versions used in conjunction with TEG 5000 are 1.1.0, 3.0.0, 4.0.0, 4.1.0 and 4.1.1. Intended: For in vitro coagulation studies
Product code
JPA System, Multipurpose For In Vitro Coagulation Studies
Reason for recall
Software defect in TEG Manager impacts the displayed alert for out of range test results. Due to this defect, reference range values received from TEG 5000 and displayed on the TEG Manager test result screen are rounded to the nearest whole number and lead to TEG Manager displaying an out of range alert when the test result is actually in range, or vice versa.
Root cause tag
software
FDA root cause
Software design
Action
Haemonetics sent US customers using a TEG 5000 device and TEG Manager software a customer letter via email on February 19, 2020. This customer letter notified end users that Haemonetics is conducting a voluntary correction of all TEG Manager software used in conjunction with the TEG 5000 device. Letter states reason for recall, health risk and action to take: Haemonetics is developing a patch to correct the issue with the TEG Manager software. The patch is expected to be available in March of 2020. Haemonetics will contact customers when the TEG Manager software patch is available for download and we will follow up with each user to ensure that the patch has been received and implemented. In the meantime, customers using TEG Manager with the TEG 5000 device should continue to follow the instructions in the TEG 5000 user manual, which state that, Before making any decisions, the attendant physician must consider all clinical information about the patients condition, the procedure, and previous therapy. Users should rely on the actual value of each test result which is correctly displayed on the TEG 5000 and TEG Manager and should not make clinical decisions based solely on the out of range alerts displayed by TEG Manager software. Recipients of this notice should complete the attached acknowledgement form in its entirety.
Quantity in commerce
88 units
Distribution
US Nationwide distribution.
Product codes and lots
TEG Manager software versions used in conjunction with TEG 5000 are 1.1.0, 3.0.0, 4.0.0, 4.1.0, and 4.1.1.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1617-2020
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1617-2020Class IITerminatedVoluntary: Firm initiated